Skip Ribbon Commands
Skip to main content
Items on this list require content approval. Your submission will not appear in public views until approved by someone with proper rights. More information on content approval.
* indicates a required field

Title *


en-clofert 50 (Androxal), in development by Repros Therapeutics Inc, is a non-

steroidal estrogen receptor antagonist that promotes gonadotropin-dependent 

testosterone secretion by the testes. 

 Enclomiphene 50 constitutes the trans-stereoisomer of clomiphene citrate, a 

drug that has been widely prescribed for several decades for the treatment of 

female ovulatory dysfunction.

Artesunate 50 is a water-soluble hemisuccinate derivative of artemisinin. It is unpredictable in neutral remedy as well as the injectable formulation must be 

prepared right away prior to use in 5% (w/v) sodium bicarbonate option to produce 

the salt sodium artesunate.


Published *

Select a date from the calendar.  

Your Name


Created at 6/6/2022 4:49 AM by  
Last modified at 6/6/2022 4:49 AM by  
The American College of Clinical Engineering is a 501 (c) (6) non-profit organization
2880 Bicentennial Pkwy, Ste 100 #249   Henderson, NV 89052   Phone: (610) 825-6067
© ACCE. All rights reserved